EASL clinical practical guidelines: Management of alcoholic liver disease

Journal of Hepatology

Volumn 57, Issue 2, 2012, Pages 399-420

  Mathurin, Philippe ^b   Hadengue, Antoine ^b   Bataller, Ramon ^b   Addolorato, Giovanni ^b   Burra, Patrizia ^b   Burt, Alastair ^b   Caballeria, Juan ^b   Cortez Pinto, Helena ^b   Day, Chris P ^b   Forrest, Ewan H ^b   Gual, Antoni ^b   Leon, David A ^b   Lligoña, Anna ^b   Jepsen, Peter ^b   Mueller, Sebastian ^b   Pageaux, Georges Philippe ^b   Roskams, Tania ^b   Seitz, Helmut K ^b   Stickel, Felix ^b   Thursz, Mark ^b   Naveau, Sylvie ^b   Morgan, Tim ^b   Nevens, Frederik ^b   more..

^a CH 1205   (Switzerland)

^b NONE

Author keywords

Alcoholic liver disease; Diagnosis; EASL guidelines; Pathogenesis; Treatment

Indexed keywords

ACETYLCYSTEINE; ALBUMIN; BACLOFEN; BILIRUBIN; CREATININE; INFLIXIMAB; PENTOXIFYLLINE; PREDNISOLONE; UREA;

AGE; ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL WITHDRAWAL; ALCOHOLIC FATTY LIVER; ALCOHOLISM; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; ELASTOGRAPHY; ENTERIC FEEDING; EUROPE; FATTY LIVER; FOLLOW UP; GLASGOW OUTCOME SCALE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE; LIVER BIOPSY; LIVER CANCER; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MENTAL PATIENT; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RELAPSE; REVIEW; RISK ASSESSMENT; SCREENING TEST; SURVIVAL;

EID: 84863967084     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.04.004     Document Type: Article

References (254)

1. V.H. Shah Alcoholic liver disease: the buzz may be gone, but the hangover remains Hepatology 51 2009 1483 1484
2. B. Gao, and R. Bataller Alcoholic liver disease: pathogenesis and new therapeutic targets Gastroenterology 141 2011 1572 1585
3. G.H. Guyatt, A.D. Oxman, R. Kunz, Y. Falck-Ytter, G.E. Vist, and A. Liberati Going from evidence to recommendations Br Med J 336 2008 1049 1051
4. J. Rehm, C. Mathers, S. Popova, M. Thavorncharoensap, Y. Teerawattananon, and J. Patra Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders Lancet 373 2009 2223 2233
5. D. Roulot, J.L. Costes, J.F. Buyck, U. Warzocha, N. Gambier, and S. Czernichow Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years Gut 60 2010 977 984
6. W.A. Zatonski, U. Sulkowska, M. Manczuk, J. Rehm, P. Boffetta, and A.B. Lowenfels Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe Eur Addict Res 16 2010 193 201
7. D.A. Leon, and J. McCambridge Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data Lancet 367 2006 52 56
8. K. Parna, and K. Rahu Dramatic increase in alcoholic liver cirrhosis mortality in Estonia in 1992-2008 Alcohol Alcohol 45 2010 548 551
9. S.J. Thomson, S. Westlake, T.M. Rahman, M.L. Cowan, A. Majeed, and J.D. Maxwell Chronic liver disease - an increasing problem: a study of hospital admission and mortality rates in England, 1979-2005, with particular reference to alcoholic liver disease Alcohol Alcohol 43 2008 416 422
10. C. Welch, D. Harrison, A. Short, and K. Rowan The increasing burden of alcoholic liver disease on United Kingdom critical care units: secondary analysis of a high quality clinical database J Health Serv Res Policy 13 2008 40 44
11. G. Bell, and A. Cremona Alcohol and death certification: a survey of current practice and attitudes Br Med J (Clin Res Ed) 295 1987 95
12. M. Ramstedt Alcohol consumption and liver cirrhosis mortality with and without mention of alcohol - the case of Canada Addiction 98 2003 1267 1276
13. S. Zakhari, and T.K. Li Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease Hepatology 46 2007 2032 2039
14. S. Popova, J. Rehm, J. Patra, and W. Zatonski Comparing alcohol consumption in central and Eastern Europe to other European countries Alcohol Alcohol 42 2007 465 473
15. M. Ramstedt Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries Addiction 96 2001 S19 S33
16. P. Mathurin, and P. Deltenre Effect of binge drinking on the liver: an alarming public health issue? Gut 58 2009 613 617
17. J. Rehm, F. Kanteres, and D.W. Lachenmeier Unrecorded consumption, quality of alcohol and health consequences Drug Alcohol Rev 29 2010 426 436
18. J. Gill, C. Tsang, H. Black, and J. Chick Can part of the health damage linked to alcohol misuse in Scotland be attributable to the type of drink and its low price (by permitting a rapid rate of consumption)? A point of view Alcohol Alcohol 45 2010 398 400
19. K. Lang, M. Vali, S. Szucs, R. Adany, and M. McKee The composition of surrogate and illegal alcohol products in Estonia Alcohol Alcohol 41 2006 446 450
20. M. McKee, S. Suzcs, A. Sarvary, R. Adany, N. Kiryanov, and L. Saburova The composition of surrogate alcohols consumed in Russia Alcohol Clin Exp Res 29 2005 1884 1888
21. S. Szucs, A. Sarvary, M. McKee, and R. Adany Could the high level of cirrhosis in central and Eastern Europe be due partly to the quality of alcohol consumed? An exploratory investigation Addiction 100 2005 536 542
22. A. Gil, O. Polikina, N. Koroleva, M. McKee, S. Tomkins, and D.A. Leon Availability and characteristics of nonbeverage alcohols sold in 17 Russian cities in 2007 Alcohol Clin Exp Res 33 2009 79 85
23. D.W. Lachenmeier, A.V. Samokhvalov, J. Leitz, K. Schoeberl, T. Kuballa, and I.V. Linskiy The composition of unrecorded alcohol from eastern Ukraine: is there a toxicological concern beyond ethanol alone? Food Chem Toxicol 48 2010 2842 2847
24. G. Corrao, L. Rubbiati, V. Bagnardi, A. Zambon, and K. Poikolainen Alcohol and coronary heart disease: a meta-analysis Addiction 95 2000 1505 1523
25. A.L. Klatsky Alcohol and cardiovascular diseases Expert Rev Cardiovasc Ther 7 2009 499 506
26. G. Corrao, V. Bagnardi, A. Zambon, and P. Torchio Meta-analysis of alcohol intake in relation to risk of liver cirrhosis Alcohol Alcohol 33 1998 381 392
27. J. Rehm, B. Taylor, S. Mohapatra, H. Irving, D. Baliunas, and J. Patra Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis Drug Alcohol Rev 29 2010 437 445
28. S. Casswell, and T. Thamarangsi Reducing harm from alcohol: call to action Lancet 373 2009 2247 2257
29. P. Anderson, D. Chisholm, and D.C. Fuhr Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol Lancet 373 2009 2234 2246
30. W. Miller, N. Heather, and W. Hall Calculating standard drink units: international comparisons Br J Addict 86 1991 43 47
31. J.B. Saunders, O.G. Aasland, T.F. Babor, J.R. de la Fuente, and M. Grant Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption Addiction 88 1993 791 804
32. K. Bush, D.R. Kivlahan, M.S. McDonell, S.D. Fihn, and K.A. Bradley The AUDIT Alcohol Consumption Questions (AUDIT-C): an effective brief screening test for problem drinking Arch Intern Med 158 1998 1789 1795
33. A. Gual, L. Segura, M. Contel, N. Heather, and J. Colom AUDIT-3 and AUDIT-4: effectiveness of two short forms of the alcohol use disorders identification test Alcohol Alcohol 37 2002 591 596
34. K.H. Bourdon, D.S. Rae, B.Z. Locke, W.E. Narrow, and D.A. Regier Estimating the prevalence of mental disorders in US. Adults from the Epidemiologic Catchment Area Survey Public Health Rep 107 1992 663 668
35. B.F. Grant, D.S. Hasin, S.P. Chou, F.S. Stinson, and D.A. Dawson Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions Arch Gen Psychiatry 61 2004 1107 1115
36. J. Altamirano, and R. Bataller Cigarette smoking and chronic liver diseases Gut 59 2010 1159 1162
37. D.A. Fiellin, P.G. O'Connor, E.S. Holmboe, and R.I. Horwitz Risk for delirium tremens in patients with alcohol withdrawal syndrome Subst Abuse 23 2002 83 94
38. L. Amato, S. Minozzi, S. Vecchi, and M. Davoli Benzodiazepines for alcohol withdrawal Cochrane Database Syst Rev 3 2010 CD005063
39. M.F. Mayo-Smith, L.H. Beecher, T.L. Fischer, D.A. Gorelick, J.L. Guillaume, and A. Hill Management of alcohol withdrawal delirium. An evidence-based practice guideline Arch Intern Med 164 2004 1405 1412
40. A. McKeon, M.A. Frye, and N. Delanty The alcohol withdrawal syndrome J Neurol Neurosurg Psychiatry 79 2008 854 862
41. M.F. Mayo-Smith Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal; JAMA 278 1997 144 151
42. M. Bayard, J. McIntyre, K.R. Hill, and J. Woodside Jr. Alcohol withdrawal syndrome Am J Fam Physician 69 2004 1443 1450
43. G. Addolorato, L. Leggio, L. Abenavoli, R. Agabio, F. Caputo, and E. Capristo Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study versus diazepam Am J Med 119 2006 13 18
44. L. Leggio, G. Kenna, and R. Swift New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1106 1117
45. H. Krampe, and H. Ehrenreich Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment Curr Pharm Des 16 2010 2076 2090
46. X. Forns, J. Caballería, M. Bruguera, J.M. Salmerón, A. Vilella, and A. Mas Disulfiram-induced hepatitis. Report of four cases and review of the literature J Hepatol 21 1994 853 857
47. R.F. Anton Naltrexone for the management of alcohol dependence N Engl J Med 359 2008 715 721
48. F. Kiefer, and K. Mann Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy Curr Pharm Des 16 2010 2098 2102
49. R.F. Anton, S.S. O'Malley, D.A. Ciraulo, R.A. Cisler, D. Couper, and D.M. Donovan Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial JAMA 295 2006 2003 2017
50. J.C. Garbutt, H.R. Kranzler, S.S. O'Malley, D.R. Gastfriend, H.M. Pettinati, and B.L. Silverman Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial JAMA 293 2005 1617 1625
51. S. Rösner, A. Hackl-Herrwerth, S. Leucht, P. Lehert, S. Vecchi, and M. Soyka Acamprosate for alcohol dependence Cochrane Database Syst Rev 9 2010 CD004332
52. G. Addolorato, L. Leggio, A. Ferrulli, F. Caputo, and A. Gasbarrini The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data Expert Opin Investig Drugs 18 2009 675 686
53. M. Heilig, and M. Egli Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms Pharmacol Ther 111 2006 855 876
54. B.A. Johnson, N. Rosenthal, J.A. Capece, F. Wiegand, L. Mao, and K. Beyers Topiramate for treating alcohol dependence: a randomized controlled trial JAMA 298 2007 1641 1651
55. B.A. Johnson, N. Rosenthal, J.A. Capece, F. Wiegand, L. Mao, and K. Beyers Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial Arch Intern Med 168 2008 1188 1199
56. B.A. Johnson Medication treatment of different types of alcoholism Am J Psychiatry 167 2010 630 639
57. G. Addolorato, and L. Leggio Safety and efficacy of baclofen in the treatment of alcohol dependent patients Curr Pharm Des 16 2010 2113 2117
58. G. Addolorato, L. Leggio, A. Ferrulli, S. Cardone, L. Vonghia, and A. Mirijello Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study Lancet 370 2007 1915 1922
59. E.F. Kaner, H.O. Dickinson, F. Beyer, E. Pienaar, C. Schlesinger, and F. Campbell The effectiveness of brief alcohol interventions in primary care settings: a systematic review Drug Alcohol Rev 28 2009 301 323
60. E.I. Vasilaki, S.G. Hosier, and W.M. Cox The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review Alcohol Alcohol 41 2006 328 335
61. M.R. Teli, C.P. Day, A.D. Burt, M.K. Bennett, and O.F. James Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver Lancet 346 1995 987 990
62. E. Baraona, and C.S. Lieber Alcohol and lipids M. Galanter, The consequences of alcoholism 1998 Plenum Press New York 97 134
63. M. You, R.V. Considine, T.C. Leone, D.P. Kelly, and D.W. Crabb Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice Hepatology 42 2005 568 577
64. T. Nakajima, Y. Kamijo, N. Tanaka, E. Sugiyama, E. Tanaka, and K. Kiyosawa Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage Hepatology 40 2004 972 980
65. C. Ji, C. Chan, and N. Kaplowitz Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model J Hepatol 45 2006 717 724
66. A. Chedid, C.L. Mendenhall, P. Gartside, S.W. French, T. Chen, and L. Rabin Prognostic factors in alcoholic liver disease. VA Cooperative Study Group Am J Gastroenterol 86 1991 210 216
67. O. Niemela, T. Juvonen, and S. Parkkila Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption J Clin Invest 87 1991 1367 1374
68. J.A. Theruvathu, P. Jaruga, R.G. Nath, M. Dizdaroglu, and P.J. Brooks Polyamines stimulate the formation of mutagenic 1,N2-propanodeoxyguanosine adducts from acetaldehyde Nucleic Acids Res 33 2005 3513 3520
69. H.K. Seitz, and F. Stickel Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress Biol Chem 387 2006 349 360
70. Y. Wang, G. Millonig, J. Nair, E. Patsenker, F. Stickel, and S. Mueller Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease Hepatology 50 2009 453 461
71. E. Albano Alcohol, oxidative stress and free radical damage Proc Nutr Soc 65 2006 278 290
72. C.S. Lieber Cytochrome P-4502E1: its physiological and pathological role Physiol Rev 77 1997 517 544
73. I. Dupont, D. Lucas, P. Clot, C. Menez, and E. Albano Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics J Hepatol 28 1998 564 571
74. D. Seth, M.D. Gorrell, S. Cordoba, G.W. McCaughan, and P.S. Haber Intrahepatic gene expression in human alcoholic hepatitis J Hepatol 45 2006 306 320
75. R. Urbaschek, R.S. McCuskey, V. Rudi, K.P. Becker, F. Stickel, and B. Urbaschek Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease Alcohol Clin Exp Res 25 2001 261 268
76. R.G. Thurman II Alcoholic liver injury involves activation of Kupffer cells by endotoxin Am J Physiol 275 1998 G605 G611
77. F. Bardag-Gorce, Q.X. Yuan, J. Li, B.A. French, C. Fang, and M. Ingelman-Sundberg The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol Biochem Biophys Res Commun 279 2000 23 29
78. R. Bataller, and D.A. Brenner Liver fibrosis J Clin Invest 115 2005 209 218
79. F.J. Cubero, R. Urtasun, and N. Nieto Alcohol and liver fibrosis Semin Liver Dis 29 2009 211 221
80. M. Moreno, and R. Bataller Cytokines and renin-angiotensin system signaling in hepatic fibrosis Clin Liver Dis 12 2008 825 852
81. D. Firrincieli, M. Boissan, and N. Chignard Epithelial-mesenchymal transition in the liver Gastroenterol Clin Biol 34 2010 523 528
82. U. Becker, A. Deis, T.I. Sorensen, M. Gronbaek, K. Borch-Johnsen, and C.F. Muller Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study Hepatology 23 1996 1025 1029
83. S. Bellentani, G. Saccoccio, G. Costa, C. Tiribelli, F. Manenti, and M. Sodde Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group Gut 41 1997 845 850
84. U. Becker, M. Gronbaek, D. Johansen, and T.I. Sorensen Lower risk for alcohol-induced cirrhosis in wine drinkers Hepatology 35 2002 868 875
85. S. Pelletier, E. Vaucher, R. Aider, S. Martin, P. Perney, and J.L. Balmes Wine consumption is not associated with a decreased risk of alcoholic cirrhosis in heavy drinkers Alcohol Alcohol 37 2002 618 621
86. E. Barrio, S. Tome, I. Rodriguez, F. Gude, J. Sanchez-Leira, and E. Perez-Becerra Liver disease in heavy drinkers with and without alcohol withdrawal syndrome Alcohol Clin Exp Res 28 2004 131 136
87. H. Wechsler, and S.B. Austin Binge drinking: the five/four measure J Stud Alcohol 59 1998 122 124
88. J. Hatton, A. Burton, H. Nash, E. Munn, L. Burgoyne, and N. Sheron Drinking patterns, dependency and life-time drinking history in alcohol-related liver disease Addiction 104 2009 587 592
89. X.L. Lu, J.Y. Luo, M. Tao, Y. Gen, P. Zhao, and H.L. Zhao Risk factors for alcoholic liver disease in China World J Gastroenterol 10 2004 2423 2426
90. G. Corrao, A.R. Lepore, P. Torchio, M. Valenti, G. Galatola, and A. D'Amicis The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease Eur J Epidemiol 10 1994 657 664
91. A.L. Klatsky, C. Morton, N. Udaltsova, and G.D. Friedman Coffee, cirrhosis, and transaminase enzymes Arch Intern Med 166 2006 1190 1195
92. K. Tanaka, S. Tokunaga, S. Kono, S. Tokudome, T. Akamatsu, and T. Moriyama Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers Int J Epidemiol 27 1998 438 443
93. S. Loft, K.L. Olesen, and M. Dossing Increased susceptibility to liver disease in relation to alcohol consumption in women Scand J Gastroenterol 22 1987 1251 1256
94. R. Norton, R. Batey, T. Dwyer, and S. MacMahon Alcohol consumption and the risk of alcohol related cirrhosis in women Br Med J (Clin Res Ed) 295 1987 80 82
95. A. Pares, J. Caballeria, M. Bruguera, M. Torres, and J. Rodes Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage J Hepatol 2 1986 33 42
96. N. Sato, K.O. Lindros, E. Baraona, K. Ikejima, E. Mezey, and H.A. Jarvelainen Sex difference in alcohol-related organ injury Alcohol Clin Exp Res 25 2001 40S 45S
97. P.K. Eagon Alcoholic liver injury: influence of gender and hormones World J Gastroenterol 16 2010 1377 1384
98. M. Frezza, C. di Padova, G. Pozzato, M. Terpin, E. Baraona, and C.S. Lieber High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism N Engl J Med 322 1990 95 99
99. S. Mandayam, M.M. Jamal, and T.R. Morgan Epidemiology of alcoholic liver disease Semin Liver Dis 24 2004 217 232
100. S.H. Stewart, and G.J. Connors Ethnicity, alcohol drinking and changes in transaminase activity among heavy drinkers J Natl Med Assoc 99 2007 564 569
101. S.N. Wickramasinghe, B. Corridan, J. Izaguirre, R. Hasan, and D.H. Marjot Ethnic differences in the biological consequences of alcohol abuse: a comparison between south Asian and European males Alcohol Alcohol 30 1995 675 680
102. F.S. Stinson, B.F. Grant, and M.C. Dufour The critical dimension of ethnicity in liver cirrhosis mortality statistics Alcohol Clin Exp Res 25 2001 1181 1187
103. S. Naveau, V. Giraud, E. Borotto, A. Aubert, F. Capron, and J.C. Chaput Excess weight risk factor for alcoholic liver disease Hepatology 25 1997 108 111
104. B. Raynard, A. Balian, D. Fallik, F. Capron, P. Bedossa, and J.C. Chaput Risk factors of fibrosis in alcohol-induced liver disease Hepatology 35 2002 635 638
105. S. Bellentani, G. Pozzato, G. Saccoccio, M. Crovatto, L.S. Croce, and L. Mazzoran Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study Gut 44 1999 874 880
106. S. Boccato, R. Pistis, F. Noventa, M. Guido, L. Benvegnu, and A. Alberti Fibrosis progression in initially mild chronic hepatitis C J Viral Hepat 13 2006 297 302
107. F. Pessione, F. Degos, P. Marcellin, V. Duchatelle, C. Njapoum, and M. Martinot-Peignoux Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C Hepatology 27 1998 1717 1722
108. L. Serfaty, O. Chazouilleres, A. Poujol-Robert, L. Morand-Joubert, C. Dubois, and Y. Chretien Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study Hepatology 26 1997 776 779
109. T.E. Wiley, M. McCarthy, L. Breidi, and T.J. Layden Impact of alcohol on the histological and clinical progression of hepatitis C infection Hepatology 28 1998 805 809
110. D.R. Harris, R. Gonin, H.J. Alter, E.C. Wright, Z.J. Buskell, and F.B. Hollinger The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse Ann Intern Med 134 2001 120 124
111. M.V. Machado, P. Ravasco, A. Martins, M.R. Almeida, M.E. Camilo, and H. Cortez-Pinto Iron homeostasis and H63D mutations in alcoholics with and without liver disease World J Gastroenterol 15 2009 106 111
112. N. Ganne-Carrie, C. Christidis, C. Chastang, M. Ziol, F. Chapel, and F. Imbert-Bismut Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow-up study Gut 46 2000 277 282
113. P. Ropero Gradilla, A. Villegas Martinez, M. Fernandez Arquero, J.A. Garcia-Agundez, F.A. Gonzalez Fernandez, and J. Benitez Rodriguez C282Y and H63D mutations of HFE gene in patients with advanced alcoholic liver disease Rev Esp Enferm Dig 93 2001 156 163
114. Z. Hrubec, and G.S. Omenn Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans Alcohol Clin Exp Res 5 1981 207 215
115. T. Reed, W.F. Page, R.J. Viken, and J.C. Christian Genetic predisposition to organ-specific end points of alcoholism Alcohol Clin Exp Res 20 1996 1528 1533
116. E. Zintzaras, I. Stefanidis, M. Santos, and F. Vidal Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology 43 2006 352 361
117. F. Stickel, and C.H. Osterreicher The role of genetic polymorphisms in alcoholic liver disease Alcohol Alcohol 41 2006 209 224
118. C. Tian, R.P. Stokowski, D. Kershenobich, D.G. Ballinger, and D.A. Hinds Variant in PNPLA3 is associated with alcoholic liver disease Nat Genet 42 2010 21 23
119. F. Stickel, S. Buch, K. Lau, H. Meyer zu Schwabedissen, T. Berg, and M. Ridinger Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians Hepatology 53 2010 86 95
120. R.N. MacSween, and A.D. Burt Histologic spectrum of alcoholic liver disease Semin Liver Dis 6 1986 221 232
121. J.H. Lefkowitch Morphology of alcoholic liver disease Clin Liver Dis 9 2005 37 53
122. P.D. Hall Pathological spectrum of alcoholic liver disease Alcohol Alcohol 2 1994 303 313
123. H.A. Edmondson, R.L. Peters, H.H. Frankel, and S. Borowsky The early stage of liver injury in the alcoholic Medicine (Baltimore) 46 1967 119 129
124. M.R. Telli, C.P. Day, A.D. Burt, M.K. Bennett, and O.F. James Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver Lancet 346 1995 987 990
125. J.T. Galambos, and R. Shapira Natural history of alcoholic hepatitis J Clin Invest 52 1973 2952 2962
126. U.A. Marbet, L. Bianchi, U. Meury, and G.A. Stalder Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease J Hepatol 4 1987 364 372
127. M. Nakano, T.M. Worner, and C.S. Lieber Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression Gastroenterology 83 1982 777 785
128. T.M. Worner, and C.S. Lieber Perivenular fibrosis as precursor lesion of cirrhosis JAMA 254 1985 627 630
129. J.T. Galambos Natural history of alcoholic hepatitis Gastroenterology 63 1972 1026 1035
130. T.I. Sorensen, M. Orholm, K.D. Bentsen, G. Hoybye, K. Eghoje, and P. Christoffersen Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis Lancet 2 1984 241 244
131. P. Mathurin, F. Beuzin, A. Louvet, N. Carrie-Ganne, A. Balian, and J.C. Trinchet Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features Aliment Pharmacol Ther 25 2007 1047 1054
132. S. Naveau, G. Gaude, A. Asnacios, H. Agostini, A. Abella, and N. Barri-Ova Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease Hepatology 49 2009 97 105
133. I.A. Bouchier, W.S. Hislop, and R.J. Prescott A prospective study of alcoholic liver disease and mortality J Hepatol 16 1992 290 297
134. B. Hock, M. Schwarz, I. Domke, V.P. Grunert, M. Wuertemberger, and U. Schiemann Validity of carbohydrate-deficient transferrin (% CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin Addiction 100 2005 1477 1486
135. H. Bell, C.M. Tallaksen, K. Try, and E. Haug Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department Alcohol Clin Exp Res 18 1994 1103 1108
136. H.K. Seitz Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase Am J Clin Nutr 83 2006 1252 1253
137. F. Imbert-Bismut, V. Ratziu, L. Pieroni, F. Charlotte, Y. Benhamou, and T. Poynard Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Lancet 357 2001 1069 1075
138. T. Poynard, A. Aubert, P. Bedossa, A. Abella, S. Naveau, and F. Paraf A simple biological index for detection of alcoholic liver disease in drinkers Gastroenterology 100 1991 1397 1402
139. K. Puukka, J. Hietala, H. Koivisto, P. Anttila, R. Bloigu, and O. Niemela Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase activity Am J Clin Nutr 83 2006 1351 1354 quiz 1448-1449
140. A. Cohen J, and M.M. Kaplan The SGOT/SGPT ratio - an indicator of alcoholic liver disease Dig Dis Sci 24 1979 835 838
141. B. Nalpas, A. Vassault, S. Charpin, B. Lacour, and P. Berthelot Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit Hepatology 6 1986 608 614
142. H. Nyblom, U. Berggren, J. Balldin, and R. Olsson High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking Alcohol Alcohol 39 2004 336 339
143. C.S. Lieber, D.G. Weiss, T.R. Morgan, and F. Paronetto Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis Am J Gastroenterol 101 2006 1500 1508
144. S. Naveau, B. Raynard, V. Ratziu, A. Abella, F. Imbert-Bismut, and D. Messous Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease Clin Gastroenterol Hepatol 3 2005 167 174
145. P. Cales, F. Oberti, S. Michalak, I. Hubert-Fouchard, M.C. Rousselet, and A. Konate A novel panel of blood markers to assess the degree of liver fibrosis Hepatology 42 2005 1373 1381
146. W.M. Rosenberg, M. Voelker, R. Thiel, M. Becka, A. Burt, and D. Schuppan Serum markers detect the presence of liver fibrosis: a cohort study Gastroenterology 127 2004 1704 1713
147. J. Parkes, P. Roderick, S. Harris, C. Day, D. Mutimer, and J. Collier Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease Gut 59 2010 1245 1251
148. S. Mueller, G. Millonig, L. Sarovska, S. Friedrich, F.M. Reimann, and M. Pritsch Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis World J Gastroenterol 16 2010 966 972
149. P. Nahon, A. Kettaneh, J. Tengher-Barna, M. Ziol, V. de Lédinghen, and C. Douvin Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease J Hepatol 49 2008 1062 1068
150. E. Nguyen-Khac, D. Chatelain, B. Tramier, C. Decrombecque, B. Robert, and J.P. Joly Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests Aliment Pharmacol Ther 28 2008 1188 1198
151. E. Nguyen-Khac, P. Saint-Leger, B. Tramier, H. Coevoet, D. Capron, and J.L. Dupas Noninvasive diagnosis of large esophageal varices by Fibroscan: strong influence of the cirrhosis etiology Alcohol Clin Exp Res 34 2010 1146 1153
152. F. Janssens, N. de Suray, H. Piessevaux, Y. Horsmans, P. de Timary, and P. Starkel Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: a real-life study J Clin Gastroenterol 44 2010 575 582
153. J. Foucher, E. Chanteloup, J. Vergniol, L. Castera, B. Le Bail, and X. Adhoute Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study Gut 55 2006 403 408
154. S. Mueller, and L. Sandrin Liver stiffness: a novel parameter for the diagnosis of liver disease Hepatic Med Evid Res 2 2010 49 67
155. L. Castera, and M. Pinzani Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 59 2010 861 866
156. E. Gelsi, R. Dainese, R. Truchi, E. Marine-Barjoan, R. Anty, and M. Autuori Effect of detoxification on liver stiffness assessed by Fibroscan ((R)) in alcoholic patients Alcohol Clin Exp Res 35 2011 566 570
157. M. Zoli, M.R. Cordiani, G. Marchesini, T. Lervese, A.M. Labate, and C. Bonazzi Prognostic indicators in compensated cirrhosis Am J Gastroenterol 86 1991 1508 1513
158. G. d'Assignies, M. Ruel, A. Khiat, L. Lepanto, M. Chagnon, and C. Kauffmann Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods Eur Radiol 19 2009 2033 2040
159. M. Mancini, A. Prinster, G. Annuzzi, R. Liuzzi, R. Giacco, and C. Medagli Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy Metabolism 58 2009 1724 1730
160. V. Ratziu, S. Bellentani, H. Cortez-Pinto, C. Day, and G. Marchesini A position statement on NAFLD/NASH based on the EASL 2009 special conference J Hepatol 53 2010 372 384
161. T.D. Sandahl, P. Jepsen, K.L. Thomsen, and H. Vilstrup Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study J Hepatol 54 2011 760 764
162. P. Kryger, P. Schlichting, O. Dietrichson, and E. Juhl The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Clinical versus morphological diagnosis Scand J Gastroenterol 18 1983 691 696
163. R.P. Mookerjee, C. Lackner, R. Stauber, V. Stadlbauer, M. Deheragoda, and A. Aigelsreiter The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis J Hepatol 55 2011 1103 1111
164. M.J. Ramond, T. Poynard, B. Rueff, P. Mathurin, C. Theodore, and J.C. Chaput A randomized trial of prednisolone in patients with severe alcoholic hepatitis N Engl J Med 326 1992 507 512
165. A. Katoonizadeh, W. Laleman, C. Verslype, A. Wilmer, G. Maleux, and T. Roskams Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study Gut 59 2011 1561 1569
166. M. Lucey, P. Mathurin, and T.R. Morgan Alcoholic hepatitis N Engl J Med 360 2009 2758 2769
167. W.C. Maddrey, J.K. Boitnott, M.S. Bedine, F.L. Weber, E. Mezey, and R.I. White Corticosteroid therapy of alcoholic hepatitis Gastroenterology 75 1978 193 199
168. R.L. Carithers Jr., H.F. Herlong, A.M. Diehl, E.W. Shaw, B. Combes, and H.J. Fallon Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial Ann Intern Med 110 1989 685 690
169. M. Phillips, H. Curtis, B. Portmann, N. Donaldson, A. Bomford, and J. O'Grady Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis - a randomised clinical trial J Hepatol 44 2006 784 790
170. M. Dominguez, D. Rincon, J.G. Abraldes, R. Miquel, J. Colmenero, and P. Bellot A new scoring system for prognostic stratification of patients with alcoholic hepatitis Am J Gastroenterol 103 2008 2747 2756
171. W. Dunn, L.H. Jamil, L.S. Brown, R.H. Wiesner, W.R. Kim, and K.V.N. Menon MELD accurately predicts mortality in patients with alcoholic hepatitis Hepatology 41 2005 353 358
172. E.H. Forrest, C.D. Evans, S. Stewart, M. Phillips, Y.H. Oo, and N.C. McAvoy Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score Gut 54 2005 1174 1179
173. W. Srikureja, N.L. Kyulo, B.A. Runyon, and K.Q. Hu Meld is a better prognostic model than Child-Turcotte-Pugh score or discriminant function score in patients with alcoholic hepatitis J Hepatol 42 2005 700 706
174. A. Louvet, S. Naveau, M. Abdelnour, M.J. Ramond, E. Diaz, and L. Fartoux The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids Hepatology 45 2007 1348 1354
175. P. Mathurin, J. O'Grady, R.L. Carithers, M. Phillips, A. Louvet, and C.L. Mendenhall Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data Gut 60 2011 255 260
176. R. Moreau, and D. Lebrec Acute rena failure in patients with cirrhosis: perspectives in the age of MELD Hepatology 37 2003 233 243
177. A. Louvet, F. Wartel, H. Castel, S. Dharancy, A. Hollebecque, and V. Canva-Delcambre Prospective screening of infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor Gastroenterology 137 2009 541 548
178. T.F. Imperiale, J. O'Connor, and A.J. McCullough Corticosteroids are effective in patients with severe alcoholic patients Am J Gastroenterol 94 1999 3066 3067
179. J.P. Daures, P. Peray, P. Bories, P. Blanc, A. Youfsi, and H. Michel Place de la corticothérapie dans le traitement des hépatites alcooliques aiguës. Résultats d'une méta-analyse Gastroenterol Clin Biol 15 1991 223 228
180. T.F. Imperiale, and A.J. McCullough Do corticosteroids reduce mortality from alcoholic hepatitis? Ann Intern Med 113 1990 299 307
181. T.B. Reynolds Corticosteroid therapy of alcoholic hepatitis: how many studies it will take? Hepatology 12 1990 619 621
182. E. Christensen, and C. Gludd Glucocorticosteroids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables Gut 37 1995 113 118
183. A. Rambaldi, H.H. Saconato, E. Christensen, K. Thordlund, J. Wetterslev, and C. Gluud Systematic review: glucocorticosteroids for alcoholic hepatitis - a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials Aliment Pharmacol Ther 27 2008 1167 1178
184. E. Cabre, P. Rodriguez-Iglesias, J. Caballeria, J.C. Quer, J.L. Sanchez-Lombrana, and A. Pares Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial Hepatology 32 2000 36 42
185. C.L. Mendenhall, S. Anderson, P. Garcia-Pont, S. Goldberg, T. Kiernan, and L.B. Seef Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone N Engl J Med 311 1984 1464 1470
186. P. Mathurin, M. Abdelnour, M.J. Ramond, N. Carbonnell, L. Fartoux, and L. Serfaty Early change in bilirubin levels (ECBL) is an important prognostic factor in severe biopsy-proven alcoholic hepatitis (AH) treated by prednisolone Hepatology 38 2003 1363 1369
187. A. Louvet, E. Diaz, S. Dharancy, H. Coevoet, F. Texier, and T. Thévenot Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids J Hepatol 48 2008 465 470
188. P. Mathurin, C. Moreno, D. Samuel, J. Dumortier, J. Salleron, and F. Durand Early liver transplantation for severe alcoholic hepatitis N Engl J Med 365 2011 1790 1800
189. E. Akriviadis, R. Botla, W. Briggs, S. Han, T. Reynolds, and O. Shakil Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial Gastroenterology 119 2000 1637 1648
190. D. Lebrec, D. Thabut, F. Oberti, J.M. Perarnau, B. Condat, and H. Barraud Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis Gastroenterology 138 2010 1755 1762
191. B. Krishna De, S. Gangopadhyay, D. Dutta, S.D. Baksi, A. Pani, and P. Ghosh Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial World J Gastroenterol 15 2009 1613 1619
192. P. Mathurin, A. Louvet, T. Dao, P. Nahon, E. Diaz, and N. Carbonell Addition of pentoxifylline to prednisolone for severe alcoholic hepatitis does not improve 6-month survival: results of the Corpentox trial Hepatology 54 2011 391A
193. L. Spahr, L. Rubbia-Brandt, J.L. Frossard, E. Giostra, A.L. Rougemont, and J. Pugin Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized pilot study J Hepatol 37 2002 448 455
194. L. Spahr, L. Rubbia-Brandt, J. Pugin, E. Giostra, J.L. Frossard, and B. Borisch Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood J Hepatol 35 2001 582 589
195. S. Naveau, S. Chollet-Martin, S. Dharancy, P. Mathurin, P. Jouet, and M.A. Piquet A double blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis Hepatology 39 2004 1390 1397
196. N.C. Boetticher, C.J. Peine, P. Kwo, G.A. Abrams, T. Patel, and B. Aqel A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis Gastroenterology 135 2008 1953 1960
197. C. Moreno, P. Langlet, A. Hittelet, L. Lasser, D. Degre, and S. Evrard Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial J Hepatol 53 2010 1117 1122
198. E. Nguyen-Khac, T. Thevenot, M.A. Piquet, S. Benferhat, O. Goria, and D. Chatelain Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis N Engl J Med 365 2011 1781 1789
199. E. Cabre, F. Gonzalez-Huix, A. Abdad-Lacruz, M. Esteve, D. Acero, and F. Fernades-Banares Effects of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics: a randomized controlled trial Gastroenterology 98 1990 715 720
200. R. Jalan, S. Sen, C. Steiner, D. Kapoor, A. Alisa, and R. Williams Extracorporeal liver support with molecular absorbents recirculating system in patients with severe alcoholic hepatitis J Hepatol 38 2003 24 31
201. P. Halle, P. Pare, K. Kaptein, G. Kanel, A.G. Redeker, and T.B. Reynolds Double-blind controlled trial of propylthiouracyl in patients with severe acute alcoholic hepatitis Gastroenterology 82 1982 925 931
202. H. Orrego, J.E. Blake, L.M. Blendis, K.V. Compton, and Y. Israel Long-term treatment of alcoholic liver disease with propylthiouracil N Engl J Med 317 1987 1421 1427
203. H. Orrego, H. Kalant, Y. Israel, J. Blake, A. Medline, and J.G. Rankin Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease Gastroenterogy 76 1978 105 115
204. E.A. Akriviadis, H. Steindel, P.C. Pinto, T.L. Fong, G. Kanel, and T.B. Reynolds Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis Gastroenterology 99 1990 811 818
205. J.C. Trinchet, M. Beaugrand, P. Callard, D.J. Hartmann, C. Gotheil, and B.V. Nusgens Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial Gastroenterol Clin Biol 13 1989 551 555
206. J.B. Saunders, J.R.F. Walters, P. Davies, and A. Paton A 20-year prospective study of cirrhosis BMJ 282 1981 263 266
207. P. Jepsen, P. Ott, P.K. Andersen, H.T. Sorensen, and H. Vilstrup The clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study Hepatology 51 2010 1675 1682
208. K.M. Fleming, G.P. Aithal, T.R. Card, and J. West The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study Aliment Pharmacol Ther 32 2010 1343 1350
209. P. Tandon, and G. Garcia-Tsao Bacterial infections, sepsis, and multiorgan failure in cirrhosis Semin Liver Dis 28 2008 26 42
210. G. N'Kontchou, J. Paries, M.T.T. Htar, N. Ganne-Carrie, L. Costentin, and V. Grando-Lemaire Risk factors for hepatocellular carcinoma in patients with alcoholic or viral c cirrhosis Clin Gastroenterol Hepatol 4 2006 1062 1068
211. V. Das, P.Y. Boelle, A. Galbois, B. Guidet, E. Maury, and N. Carbonell Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival Crit Care Med 38 2010 2108 2116
212. H. Bell, J. Jahnsen, E. Kittang, N. Raknerud, and L. Sandvik Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit Scand J Gastroenterol 39 2004 858 863
213. F. Pessione, M.J. Ramond, L. Peters, B.N. Pham, P. Batel, and B. Rueff Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence Liver Int 23 2003 45 53
214. P. Jepsen, H. Vilstrup, P.K. Andersen, T.L. Lash, and H.T. Sorensen Co-morbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study Hepatology 48 2008 214 220
215. F. Stickel, B. Hoehn, D. Schuppan, and H.K. Seitz Review article: nutritional therapy in alcoholic liver disease Aliment Pharmacol Ther 18 2003 357 373
216. J. Neuberger Transplantation for alcoholic liver disease: a perspective from Europe Liver Transpl Surg 4 1998 S51 S57
217. J. Neuberger, D. Adams, P. MacMaster, A. Maidment, and M. Speed Assessing priorities for allocation of donor liver grafts: survey of public and clinicians BMJ 317 1998 172 175
218. D. Hasin, S. McCloud, Q. Li, and J. Endicott Cross-system agreement among demographic subgroups: DSM-III, DSM-III-R, DSM-IV and ICD-10 diagnoses of alcohol use disorders Drug Alcohol Depend 41 1996 127 135
219. R. Adam, P. McMaster, J.G. O'Grady, D. Castaing, J.L. Klempnauer, and N. Jamieson Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry Liver Transpl 9 2003 1231 1243
220. P. Burra, D. Mioni, A. Cecchetto, U. Cillo, G. Zanus, and S. Fagiuoli Histological features after liver transplantation in alcoholic cirrhotics J Hepatol 34 2001 716 722
221. J. Mackie, K. Groves, A. Hoyle, C. Garcia, R. Garcia, and B. Gunson Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism Liver Transpl 7 2001 418 427
222. P. Burra, M. Senzolo, R. Adam, V. Delvart, V. Karam, and G. Germani Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry) Am J Transplant 10 2010 138 148
223. T. Poynard, S. Naveau, M. Doffoel, K. Boudjema, C. Vanlemmens, and G. Mantion Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group J Hepatol 30 1999 1130 1137
224. C. Vanlemmens, V. Di Martino, C. Milan, M. Messner, A. Minello, and C. Duvoux Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial Ann Intern Med 150 2009 153 161
225. R.L. Carithers Jr., H.F. Herlong, A.M. Diehl, E.W. Shaw, B. Combes, and H.J. Fallon Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial Ann Intern Med 110 1989 685 690
226. B.J. Veldt, F. Laine, A. Guillygomarc'h, L. Lauvin, K. Boudjema, and M. Messner Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing J Hepatol 36 2002 93 98
227. R.M. Merion, D.E. Schaubel, D.L. Dykstra, R.B. Freeman, F.K. Port, and R.A. Wolfe The survival benefit of liver transplantation Am J Transplant 5 2005 307 313
228. M.R. Lucey, D.E. Schaubel, M.K. Guidinger, S. Tome, and R.M. Merion Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit Hepatology 50 2009 400 406
229. P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, and C.L. Kosberg A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
230. M. Walter, G. Scholler, D. Moyzes, M. Hildebrandt, R. Neuhaus, and G. Danzer Psychosocial prediction of abstinence from ethanol in alcoholic recipients following liver transplantation Transplant Proc 34 2002 1239 1241
231. P. Burra, A. Smedile, M. Angelico, A. Ascione, and M. Rizzetto Liver transplantation in Italy: current status. Study Group on Liver Transplantation of the Italian Association for the Study of the Liver (A.I.S.F.) Dig Liver Dis 32 2000 249 256
232. R.G. Gish, A.H. Lee, E.B. Keeffe, H. Rome, W. Concepcion, and C.O. Esquivel Liver transplantation for patients with alcoholism and end-stage liver disease Am J Gastroenterol 88 1993 1337 1342
233. G.P. Pageaux, P. Perney, and D. Larrey Liver transplantation for alcoholic liver disease Addict Biol 6 2001 301 308
234. S. Tome, and M.R. Lucey Timing of liver transplantation in alcoholic cirrhosis J Hepatol 39 2003 302 307
235. S. Tome, C. Martinez-Rey, A. Gonzalez-Quintela, F. Gude, A. Brage, and E. Otero Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease J Hepatol 36 2002 793 798
236. S. Kenngott, A.L. Gerbes, R. Schauer, and M. Bilzer Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis Transpl Int 16 2003 639 641
237. J.F. Murray, A.M. Dawson, and S. Sherlock Circulatory changes in chronic liver disease Am J Med 24 1958 358 367
238. N. Rayes, W.O. Bechstein, H. Keck, G. Blumhardt, R. Lohmann, and P. Neuhaus Cause of death after liver transplantation: an analysis of 41 cases in 382 patients Zentralbl Chir 120 1995 435 438
239. D. Sherman, and R. Williams Liver transplantation for alcoholic liver disease J Hepatol 23 1995 474 479
240. H. Tang, R. Boulton, B. Gunson, S. Hubscher, and J. Neuberger Patterns of alcohol consumption after liver transplantation Gut 43 1998 140 145
241. R.M. Weinrieb, D.H. Van Horn, A.T. McLellan, A.I. Alterman, J.S. Calarco, and C.P. O'Brien Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed Psychosomatics 42 2001 110 116
242. R.M. Weinrieb, D.H. Van Horn, A.T. McLellan, J.R. Volpicelli, J.S. Calarco, and M.R. Lucey Drinking behavior and motivation for treatment among alcohol-dependent liver transplant candidates J Addict Dis 20 2001 105 119
243. K.A. Simo, S. Sereika, N. Bitner, K.N. Newton, and D.A. Gerber Medical epidemiology of patients surviving 10 years after liver transplantation Clin Transplant 25 2010 360 367
244. C. Duvoux, I. Delacroix, J.P. Richardet, F. Roudot-Thoraval, J.M. Metreau, and P.L. Fagniez Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis Transplantation 67 1999 418 421
245. E.B. Haagsma, V.E. Hagens, M. Schaapveld, A.P. van den Berg, E.G. de Vries, and I.J. Klompmaker Increased cancer risk after liver transplantation: a population-based study J Hepatol 34 2001 84 91
246. G.A. Berlakovich, F. Langer, E. Freundorfer, T. Windhager, S. Rockenschaub, and E. Sporn General compliance after liver transplantation for alcoholic cirrhosis Transpl Int 13 2000 129 135
247. T. Cowling, L.W. Jennings, R.M. Goldstein, E.Q. Sanchez, S. Chinnakotla, and G.B. Klintmalm Societal reintegration after liver transplantation: findings in alcohol-related and non-alcohol-related transplant recipients Ann Surg 239 2004 93 98
248. P. Mathurin, and M.R. Lucey Management of alcoholic hepatitis J Hepatol 56 2012 S39 S45